Laboratory technologies for next generation alternative testing
in vivo testing at the in vitro scale
Bridge the gap between cells and vertebrates seamlessly
Pioneering the Organism-on-Chip technologies
Micro-organisms testing made easy
We develop innovative technologies that automate end-to-end screenings on micro-organisms so you can focus on what is important: your results.
unlocking unique datapoints
By automating end-to-end micro-organisms’ experimentation, our products achieve unprecedented levels of standardization and reproducibility.
-
Failure in later stages of the R&D pipeline is especially costly. We actively pursue technologies to identify adverse toxicology as early as possible, such as Nagi Bioscience’s technologies.
Early Toxicology Safety – Agrochemical Company
Unfavorable toxicological profiles are a major cause of late failure in our discovery pipelines. Failure in later stages of the R&D pipeline is especially costly. We are actively pursuing technologies to identify adverse toxicology as early as possible, including through the use of model systems such as those being investigated by Nagi Bioscience.
Early Toxicology Safety – Agrochemical Company
-
Methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology opened many possibilities for us as a company.
CEO – Aging Biotech Company
Before proceeding to clinical trials, the efficacy of our existing drugs or combinations thereof for their positive impact on healthspan will be tested in the nematode C.elegans. However, methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology into Rejuvenate opened many possibilities for us as a company.
CEO – Aging Biotech Company
The SydLab™ universe
The first all-in-one solution for automated high-content screening on full organisms with active flow control
explore the sydlab™ research areas
Shaping the future of biological testing
Our latest news
- Nagi Bioscience raises 12.4MCHF Series A round
- Nagi Bioscience takes the stage at EUROTOX 2023
- Nagi presents SydLab™ one at Worm23
